Literature DB >> 22690260

Successful treatment of anal gland adenocarcinoma with combined modality therapy.

Sean Warsch, Ulas Darda Bayraktar, B-Chen Wen, Joseph Zeitouni, Floriano Marchetti, Caio Max S Rocha-Lima, Alberto J Montero.   

Abstract

Entities:  

Year:  2012        PMID: 22690260      PMCID: PMC3369602     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN: 1934-7820


× No keyword cloud information.
  14 in total

Review 1.  Anal canal tumors and their precursors.

Authors:  C Fenger
Journal:  Pathol Annu       Date:  1988

2.  Anal gland carcinoma.

Authors:  C M Hobbs; M A Lowry; D Owen; L H Sobin
Journal:  Cancer       Date:  2001-10-15       Impact factor: 6.860

3.  Adenocarcinoma of the anal ducts. A series of 21 cases.

Authors:  S L Jensen; M H Shokouh-Amiri; K Hagen; H Harling; O V Nielsen
Journal:  Dis Colon Rectum       Date:  1988-04       Impact factor: 4.585

4.  Chemoradiation for adenocarcinoma of the anus.

Authors:  Michael Papagikos; Christopher H Crane; John Skibber; Nora A Janjan; Barry Feig; Miguel A Rodriguez-Bigas; Arthur Hung; Robert A Wolff; Marc Delclos; Edward Lin; Karen Cleary
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-03-01       Impact factor: 7.038

5.  Adenocarcinoma of the anal glands. Results of a survey.

Authors:  M E Abel; Y S Chiu; T R Russell; P A Volpe
Journal:  Dis Colon Rectum       Date:  1993-04       Impact factor: 4.585

6.  Prognosis and recurrence patterns of anal adenocarcinoma.

Authors:  M Basik; M A Rodriguez-Bigas; R Penetrante; N J Petrelli
Journal:  Am J Surg       Date:  1995-02       Impact factor: 2.565

7.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

8.  Immunophenotypic characterization of anal gland carcinoma: loss of p63 and cytokeratin 5/6.

Authors:  Mikhail Lisovsky; Keyur Patel; Karina Cymes; Donald Chase; Tawfiqul Bhuiya; Nora Morgenstern
Journal:  Arch Pathol Lab Med       Date:  2007-08       Impact factor: 5.534

9.  Primary adenocarcinoma of the anus treated with combined modality therapy.

Authors:  Kathryn P Beal; Douglas Wong; Jose G Guillem; Philip B Paty; Leonard L Saltz; Raquel Wagman; Bruce D Minsky
Journal:  Dis Colon Rectum       Date:  2003-10       Impact factor: 4.585

10.  Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer.

Authors:  D Koeberle; R Burkhard; R von Moos; R Winterhalder; V Hess; F Heitzmann; T Ruhstaller; L Terraciano; J Neuweiler; G Bieri; C Rust; M Toepfer
Journal:  Br J Cancer       Date:  2008-03-18       Impact factor: 7.640

View more
  1 in total

1.  Renal vein tumor thrombus from metastatic anal gland adenocarcinoma.

Authors:  Ari Bernstein; Judy Sarungbam; Victoria Chernyak; Lakshmi Rajdev; Evan Kovac
Journal:  Urol Case Rep       Date:  2017-10-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.